Identification Generic Name (1S,4R,7AR)-4-BUTOXY-1-[(1R)-1-FORMYLPROPYL]-2,4,5,6,7,7A-HEXAHYDRO-1H-ISOINDOLE-3-CARBOXYLIC ACID DrugBank Accession Number DB08109 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (1S,4R,7AR)-4-BUTOXY-1-[(1R)-1-FORMYLPROPYL]-2,4,5,6,7,7A-HEXAHYDRO-1H-ISOINDOLE-3-CARBOXYLIC ACID (DB08109) ×  Close Weight Average: 309.4006  Monoisotopic: 309.194008357  Chemical Formula C 17 H 27 NO 4 Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Beta-lactamase Not Available Enterobacter cloacae Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as alpha amino acids. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). Kingdom Organic compounds Super Class Organic acids and derivatives Class Carboxylic acids and derivatives Sub Class Amino acids, peptides, and analogues Direct Parent Alpha amino acids Alternative Parents Isoindoles  /  Pyrroline carboxylic acids  /  Amino acids  /  Monocarboxylic acids and derivatives  /  Enamines  /  Dialkylamines  /  Dialkyl ethers  /  Carboxylic acids  /  Azacyclic compounds  /  Organopnictogen compounds  /  Organic oxides  /  Hydrocarbon derivatives  /  Aldehydes 
 
 
  show 3 more Substituents Aldehyde  /  Aliphatic heteropolycyclic compound  /  Alpha-amino acid  /  Amine  /  Amino acid  /  Azacycle  /  Carbonyl group  /  Carboxylic acid  /  Dialkyl ether  /  Enamine  /  Ether  /  Hydrocarbon derivative  /  Isoindole  /  Isoindole or derivatives  /  Monocarboxylic acid or derivatives  /  Organic nitrogen compound  /  Organic oxide  /  Organic oxygen compound  /  Organoheterocyclic compound  /  Organonitrogen compound  /  Organooxygen compound  /  Organopnictogen compound  /  Pyrroline  /  Pyrroline carboxylic acid  /  Pyrroline carboxylic acid or derivatives  /  Secondary aliphatic amine  /  Secondary amine 
 
 
  show 17 more Molecular Framework Aliphatic heteropolycyclic compounds External Descriptors Not Available Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key WRBRCIHZCYLBFW-KYEXWDHISA-N InChI InChI=1S/C17H27NO4/c1-3-5-9-22-13-8-6-7-12-14(13)16(17(20)21)18-15(12)11(4-2)10-19/h10-13,15,18H,3-9H2,1-2H3,(H,20,21)/t11-,12+,13+,15+/m0/s1 IUPAC Name (1S,4R,7aR)-4-butoxy-1-[(2R)-1-oxobutan-2-yl]-2,4,5,6,7,7a-hexahydro-1H-isoindole-3-carboxylic acid SMILES [H][C@](CC)(C=O)[C@@]1([H])NC(C(O)=O)=C2[C@@]1([H])CCC[C@@]2([H])OCCCC References General References Not Available External Links PubChem Compound 46937124 PubChem Substance 99444580 ChemSpider 25058525 ZINC ZINC000100036343 PDBe Ligand LK5 PDB Entries 2q9n Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.206 mg/mL ALOGPS logP 2.45 ALOGPS logP 2.1 Chemaxon logS -3.2 ALOGPS pKa (Strongest Acidic) 5.77 Chemaxon pKa (Strongest Basic) 1.81 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 5 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 75.63 Å 2 Chemaxon Rotatable Bond Count 8 Chemaxon Refractivity 84.63 m 3 ·mol -1 Chemaxon Polarizability 34.63 Å 3 Chemaxon Number of Rings 2 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 0.9795 Blood Brain Barrier - 0.6999 Caco-2 permeable - 0.612 P-glycoprotein substrate Substrate 0.7592 P-glycoprotein inhibitor I Non-inhibitor 0.8242 P-glycoprotein inhibitor II Non-inhibitor 0.9478 Renal organic cation transporter Non-inhibitor 0.8375 CYP450 2C9 substrate Non-substrate 0.8594 CYP450 2D6 substrate Non-substrate 0.8037 CYP450 3A4 substrate Substrate 0.583 CYP450 1A2 substrate Non-inhibitor 0.5344 CYP450 2C9 inhibitor Non-inhibitor 0.7456 CYP450 2D6 inhibitor Non-inhibitor 0.8513 CYP450 2C19 inhibitor Non-inhibitor 0.765 CYP450 3A4 inhibitor Non-inhibitor 0.829 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.7149 Ames test Non AMES toxic 0.6916 Carcinogenicity Non-carcinogens 0.9784 Biodegradation Not ready biodegradable 0.6386 Rat acute toxicity 2.4426 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.8303 hERG inhibition (predictor II) Non-inhibitor 0.8149    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more 
 
 
  Details 1.  Beta-lactamase Kind Protein Organism Enterobacter cloacae Pharmacological action Unknown General Function Beta-lactamase activity Specific Function This protein is a serine beta-lactamase with a substrate specificity for cephalosporins. Gene Name ampC Uniprot ID P05364 Uniprot Name Beta-lactamase Molecular Weight 41301.33 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at September 15, 2010 21:28 / Updated at June 12, 2020 16:52 